Pharma Stocks Swing after Pfizer-JNJ Release; Elan Plunges

A drug developed by Pfizer (PFE), Johnson & Johnson (JNJ) and Elan Corp. (ELN) to treat Alzheimer’s did not show effectiveness in a late-stage trial, Pfizer announced late on Monday. The news sent shares of Pfizer and J&J down less than 1%, but caused Elan to plunge 14%. “While we are disappointed in the topline [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.